AP MOELLER-MAERSK AS AAP MOELLER-MAERSK AS AAP MOELLER-MAERSK AS A

AP MOELLER-MAERSK AS A

No trades
See on Supercharts

Key facts today

Morningstar downgraded its rating on A.P. Møller - Mærsk to hold from buy while maintaining its price target at 13,700 Danish kroner.
Analyze the impactAnalyze the impact
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪25.41 B‬EUR
‪3.53 B‬EUR
‪47.19 B‬EUR
‪2.14 M‬
Beta (1Y)
0.20
Employees (FY)
‪100 K‬
Revenue / Employee (1Y)
‪520.87 K‬EUR
Net income / Employee (1Y)
‪38.99 K‬EUR

About A.P. MOLLER - MAERSK A A/S


CEO
Vincent Clerc
Website
Headquarters
Copenhagen
Founded
1904
ISIN
DK0010244425
FIGI
BBG00X8QFF74
A.P. Møller-Mærsk A/S engages in shipping, energy, transportation, offshore drilling, and retail activities. It operates through the following segments: Ocean, Logistics and Services, Terminals and Towage, and Manufacturing and Others. The Ocean segment includes global container shipping activities including strategic transhipment hubs and sale of bunker oil. The Logisticsco and Services segment comprises freight forwarding, supply chain management, inland haulage, and other logistics services. The Terminals and Towage segment focuses in the gateway terminal activities, towage, and related marine activities. The Manufacturing and Others segment involves inthe production of reefer and dry containers, providing off-shore supply service, and trading and other businesses. The company was founded by Arnold Peter Møller and Peter Mærsk Møller on April 16, 1904 and is headquartered in Copenhagen, Denmark.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
AMKB5650469
A.P. Moller - Maersk A/S 5.875% 14-SEP-2033
Yield to maturity
5.19%
Maturity date
Sep 14, 2033
XS0911553039
APMollerMaersk 4% 04/04/2025
Yield to maturity
5.13%
Maturity date
Apr 4, 2025
AMKB4847788
A.P. Moller - Maersk A/S 4.5% 20-JUN-2029
Yield to maturity
4.83%
Maturity date
Jun 20, 2029
XS277689120
A.P.MOELLER 24/36 MTN
Yield to maturity
3.40%
Maturity date
Mar 5, 2036
DP4D
A.P. MOELLER - MAERSK A/S 2021-25.11.31 REG S
Yield to maturity
3.35%
Maturity date
Nov 25, 2031
XS277689090
A.P.MOELLER 24/32 MTN
Yield to maturity
3.25%
Maturity date
Mar 5, 2032
NO0010767734
APMollerMaersk 3,3% 22/06/2026
Yield to maturity
3.17%
Maturity date
Jun 22, 2026
XS178969960
A.P.MOELLER-MAERSK 18/26
Yield to maturity
2.77%
Maturity date
Mar 16, 2026

Explore more bonds 

Frequently Asked Questions


The current price of MRSA is 1,535 EUR — it has increased by 1.64% in the past 24 hours. Watch AP MOELLER-MAERSK AS A stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on VIE exchange AP MOELLER-MAERSK AS A stocks are traded under the ticker MRSA.
MRSA stock has risen by 7.95% compared to the previous week, the month change is a 16.86% rise, over the last year AP MOELLER-MAERSK AS A has showed a 20.04% increase.
We've gathered analysts' opinions on AP MOELLER-MAERSK AS A future price: according to them, MRSA price has a max estimate of 2,315.49 EUR and a min estimate of 1,170.46 EUR. Watch MRSA chart and read a more detailed AP MOELLER-MAERSK AS A stock forecast: see what analysts think of AP MOELLER-MAERSK AS A and suggest that you do with its stocks.
MRSA reached its all-time high on Jan 13, 2022 with the price of 2,972 EUR, and its all-time low was 1,086 EUR and was reached on Sep 21, 2020. View more price dynamics on MRSA chart.
See other stocks reaching their highest and lowest prices.
MRSA stock is 5.21% volatile and has beta coefficient of 0.20. Track AP MOELLER-MAERSK AS A stock price on the chart and check out the list of the most volatile stocks — is AP MOELLER-MAERSK AS A there?
Today AP MOELLER-MAERSK AS A has the market capitalization of ‪25.01 B‬, it has increased by 4.65% over the last week.
Yes, you can track AP MOELLER-MAERSK AS A financials in yearly and quarterly reports right on TradingView.
AP MOELLER-MAERSK AS A is going to release the next earnings report on Feb 5, 2025. Keep track of upcoming events with our Earnings Calendar.
MRSA earnings for the last quarter are 177.71 EUR per share, whereas the estimation was 153.93 EUR resulting in a 15.45% surprise. The estimated earnings for the next quarter are 82.53 EUR per share. See more details about AP MOELLER-MAERSK AS A earnings.
AP MOELLER-MAERSK AS A revenue for the last quarter amounts to ‪14.51 B‬ EUR, despite the estimated figure of ‪13.91 B‬ EUR. In the next quarter, revenue is expected to reach ‪12.88 B‬ EUR.
MRSA net income for the last quarter is ‪2.78 B‬ EUR, while the quarter before that showed ‪739.77 M‬ EUR of net income which accounts for 275.17% change. Track more AP MOELLER-MAERSK AS A financial stats to get the full picture.
Yes, MRSA dividends are paid annually. The last dividend per share was 68.88 EUR. As of today, Dividend Yield (TTM)% is 4.35%. Tracking AP MOELLER-MAERSK AS A dividends might help you take more informed decisions.
AP MOELLER-MAERSK AS A dividend yield was 4.30% in 2023, and payout ratio reached 32.93%. The year before the numbers were 27.98% and 37.97% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 21, 2024, the company has ‪100.00 K‬ employees. See our rating of the largest employees — is AP MOELLER-MAERSK AS A on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. AP MOELLER-MAERSK AS A EBITDA is ‪8.60 B‬ EUR, and current EBITDA margin is 18.23%. See more stats in AP MOELLER-MAERSK AS A financial statements.
Like other stocks, MRSA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AP MOELLER-MAERSK AS A stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So AP MOELLER-MAERSK AS A technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating AP MOELLER-MAERSK AS A stock shows the buy signal. See more of AP MOELLER-MAERSK AS A technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.